Genetic Savings and Clone, a biotechnology company that sold cloned pets, sent letters to its customers last month informing them it will close at the end of the year because of little demand for costly cloned cats. The company had recently reduced the price from $50,000 to $32,000.
The letters said the Sausalito company was not accepting new orders for clones because it was “unable to develop the technology to the point that cloning pets is commercially viable.”
So says an October 11, 2006 report in the San Jose Mercury-News. The company’s web site does not (at the time blog posting is being written) reflect the idea that the company has lived most of its ninth life.
(Thanks to investigator Ian Davis for bringing this to our attention.)